TissueGen® Inc., Dallas, Texas, has developed a breakthrough drug-delivery system that consists of polymers that can be integrated into implantable fabrics and medical devices. The polymer technology includes fiber extrusion at room temperature, which preserves the biological activity of therapeutic agents that might be deteriorated under high temperature extrusion techniques. Biomedical Structures LLC, Warwick, R.I., a developer of biomedical textiles, will integrate the polymers into drug-releasing medical devices, such as small diameter vascular grafts and stents, sutures and other implantable technologies. The unique polymer process can be used for many drugs and other therapeutics, such as enzymes and growth factors, and can be custom engineered for specific applications. Drugs are incorporated into the fabrics using commercially available polymer components, including polylactic acid and polydioxanone.
Absorbable polymers deliver medications
Advanced Textiles, Industry News | August 1, 2013 | By: ATA
You might also like...
Trivantage appoints James Dillport outside sales representative
Cone Denim announces strategic transformation, plans exit from China manufacturing
New Jersey Gov. Mikie Sherrill passes PFAS bill
Lafuente Sign & Awning opens new headquarters, production facility